Medicare Enrolled
Dr. Asif Cochinwala, M.D.
Rheumatology · Cypress, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cochinwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cochinwala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cochinwala
Dr. Asif Cochinwala is a rheumatology specialist in Cypress, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cochinwala performed 24,555 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cochinwala received a total of $8,097 from 32 pharmaceutical and/or device companies across 313 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cochinwala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in TX
$8,097 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗24,555
Medicare services
Top 31% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
10,301 | $10 | $70 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,620 | $26 | $230 |
| Denosumab injection (Prolia/Xgeva) | 4,740 | $18 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
746 | $68 | $105 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
597 | $8 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
321 | $89 | $165 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
308 | $17 | $94 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
263 | $60 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
250 | $104 | $375 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
146 | $13 | $94 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
126 | $11 | $70 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 114 | $24 | $150 |
| Cardiolipin antibody (tissue antibody) measurement | 114 | $24 | $167 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
103 | $23 | $250 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
85 | $22 | $250 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
84 | $1 | $35 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
81 | $39 | $400 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
80 | $51 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $125 | $350 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
71 | $12 | $69 |
| Rheumatoid factor level | 63 | $5 | $43 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
54 | $1 | $14 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
45 | $12 | $35 |
| Measurement of dna antibody, single stranded | 44 | $12 | $50 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
30 | $22 | $125 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
28 | $18 | $125 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
24 | $51 | $90 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $84 | $200 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
19 | $39 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
66.2% high complexity
21.4% medium
12.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,097
Total received (2018-2024)
Avg $1,157/year across 7 years
Top 38% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
313
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,167
2023
$937
2022
$782
2021
$384
2020
$334
2019
$2,882
2018
$1,611
Payments by company (2024)
ABBVIE INC.
$429
UCB, Inc.
$191
AstraZeneca Pharmaceuticals LP
$147
Amgen Inc.
$79
Novartis Pharmaceuticals Corporation
$66
GlaxoSmithKline, LLC.
$57
Alvogen Inc
$49
Sandoz Inc.
$32
Fresenius Kabi USA, LLC
$28
Aurinia Pharma U.S., Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Biocon Biologics Inc
$21
Fidia Pharma USA Inc.
$20
Top 3 companies account for 65.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,069
Amgen Inc.
$1,691
UCB, Inc.
$673
Novartis Pharmaceuticals Corporation
$624
ABBVIE INC.
$564
Genentech USA, Inc.
$256
AstraZeneca Pharmaceuticals LP
$238
GlaxoSmithKline, LLC.
$230
Radius Health, Inc.
$219
Lilly USA, LLC
$178
AbbVie, Inc.
$163
Celgene Corporation
$144
AbbVie Inc.
$134
Sandoz Inc.
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
E.R. Squibb & Sons, L.L.C.
$97
Octapharma USA, Inc.
$66
Horizon Therapeutics plc
$64
Horizon Pharma plc
$63
PFIZER INC.
$60
Merck Sharp & Dohme Corporation
$57
Alvogen Inc
$49
Aurinia Pharma U.S., Inc.
$41
West-Ward Pharmaceuticals
$37
Fresenius Kabi USA, LLC
$28
Biocon Biologics Inc
$21
Mylan Institutional Inc.
$21
GENZYME CORPORATION
$20
Fidia Pharma USA Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Hikma Pharmaceuticals USA
$16
Bioventus LLC
$16
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EVENITY · Enbrel · Exogen · FORTEO · HUMIRA · HYMOVIS · HYRIMOZ · Hulio · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · Mitigare · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
49
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cochinwala is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cochinwala experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Cochinwala performed 10,301 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cochinwala receive payments from pharmaceutical companies?
Yes. Dr. Cochinwala received a total of $8,097 from 32 companies across 313 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cochinwala's costs compare to other rheumatologists in Cypress?
Dr. Cochinwala's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cochinwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Cypress
Browse rheumatologists in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology